Clinical Associate Professor Judy Kirk

Clinical Associate Professor
Medicine, Westmead Clinical School
Westmead Millennium Institute for Medical Research

C24 - Westmead Hospital
The University of Sydney
NSW 2006 Australia

T: 9845 6947
F: 9845 9217
E:

On this page

Grants | Publications

 

Current national competitive grants*

2010

Randomised trial of consumer-led familiar cancer risk tool & GP triage on risk-appropriate colorectal cancer screening
Trevena L, Meiser B, Kirk J, Barlow-Stewart K, Dobbins T, Goodwin A
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($556,250 over 4 years)

* Grants administered through the University of Sydney

Publications

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2013

   
  • Wakefield, C., Thorne, H., Kirk, J., Niedermayr, E., Doolan, E., Tucker, K. (2013), Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer. Genetics in Medicine. 15(3), 187-194. [Abstract]

2012

   
  • Meiser, B., Gleeson, M., Watts, K., Peate, M., Zilliacus, E., Barlow-Stewart, K., Saunders, C., Mitchell, G., Kirk, J. (2012), Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing. Oncology Nursing Forum. 39(2), E101-E111. [Abstract]
  • Antoniou, A., Kuchenbaecker, K., Soucy, P., Beesley, J., Chen, X., McGuffog, L., Lee, A., Barrowdale, D., Healey, S., Sinilnikova, O., Caligo, M., Loman, N., Harbst, K., Lindblom, A., Arver, B., Rosenquist, R., Karlsson, P., Nathanson, K., Domchek, S., Rebbeck, T., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Złowowcka-Perłowska, E., Osorio, A., Durán, M., Andrés, R., Benítez, J., Hamann, U., Hogervorst, F., van Os, T., Verhoef, S., Meijers-Heijboer, H., Wijnen, J., Gómez Garcia, E., Ligtenberg, M., Kriege, M., Collée, J., Ausems, M., Oosterwijk, J., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D., Lalloo, F., Jacobs, C., Eeles, R., Adlard, J., Davidson, R., Cole, T., Cook, J., Paterson, J., Douglas, F., Brewer, C., Hodgson, S., Morrison, P., Walker, L., Rogers, M., Donaldson, A., Dorkins, H., Godwin, A., Bove, B., Stoppa-Lyonnet, D., Houdayer, C., Buecher, B., de Pauw, A., Mazoyer, S., Calender, A., Léoné, M., Bressac-de Paillerets, B., Caron, O., Sobol, H., Frenay, M., Prieur, F., Ferrer, S., Mortemousque, I., Buys, S., Daly, M., Miron, A., Terry, M., Hopper, J., John, E., Southey, M., Goldgar, D., Singer, C., Fink-Retter, A., Tea, M., Kaulich, D., Hansen, T., Nielsen, F., Barkardottir, R., Gaudet, M., Kirchhoff, T., Joseph, V., Dutra-Clarke, A., Offit, K., Piedmonte, M., Kirk, J., Cohn, D., Hurteau, J., Byron, J., Fiorica, J., Toland, A., Montagna, M., Oliani, C., Imyanitov, E., Isaacs, C., Tihomirova, L., Blanco, I., Lazaro, C., Teulé, A., Valle, J., Gayther, S., Odunsi, K., Gross, J., Karlan, B., Olah, E., Teo, S., Ganz, P., Beattie, M., Dorfling, C., van Rensburg, E., Diez, O., Kwong, A., Schmutzler, R., Wappenschmidt, B., Engel, C., Meindl, A., Ditsch, N., Arnold, N., Heidemann, S., Niederacher, D., Preisler-Adams, S., Gadzicki, D., Varon-Mateeva, R., Deissler, H., Gehrig, A., Sutter, C., Kast, K., Fiebig, B., Schäfer, D., Caldes, T., de la Hoya, M., Nevanlinna, H., Muranen, T., Lespérance, B., Spurdle, A., Neuhausen, S., Ding, Y., Wang, X., Fredericksen, Z., Pankratz, V., Lindor, N., Peterlongo, P., Manoukian, S., Peissel, B., Zaffaroni, D., Bonanni, B., Bernard, L., Dolcetti, R., Papi, L., Ottini, L., Radice, P., Greene, M., Loud, J., Andrulis, I., Ozcelik, H., Mulligan, A., Glendon, G., Thomassen, M., Gerdes, A., Jensen, U., Skytte, A., Kruse, T., Chenevix-Trench, G., Couch, F., Simard, J., Easton, D. (2012), Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research. 14(1), R33. [Abstract]
  • Watts, K., Meiser, B., Mitchell, G., Kirk, J., Saunders, C., Peate, M., Duffy, J., Kelly, P., Gleeson, M., Barlow-Stewart, K., Rahman, B., Friedlander, M., Tucker, K. (2012), How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer. 12(1), 320. [Abstract]

2011

   
  • Zilliacus, E., Meiser, B., Lobb, E., Kelly, P., Barlow-Stewart, K., Kirk, J., Spigelman, A., Warwick, L., Tucker, K. (2011), Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling?. Genetics in medicine : official journal of the American College of Medical Genetics. 13(11), 933-41. [Abstract]
  • Saleh, M., Barlow-Stewart, K., Meiser, B., Kirk, J., Tucker, K. (2011), An Exploration of the Cultural Context of Kinship and Genetics Amongst Arabic-Australians: Implications for Practice. Journal of Genetic Counseling. 20(5), 465-75. [Abstract]
  • Mitra, A., Bancroft, E., Barbachano, Y., Page, E., Foster, C., Jameson, C., Mitchell, G., Lindeman, G., Stapleton, A., Suthers, G., Evans, D., Cruger, D., Blanco, I., Mercer, C., Kirk, J., Maehle, L., Hodgson, S., Walker, L., Izatt, L., Douglas, F., Tucker, K., Dorkins, H., Clowes, V., Male, A., Donaldson, A., Brewer, C., Doherty, R., Bulman, B., Osther, P., Salinas, M., Eccles, D., Axcrona, K., Jobson, I., Newcombe, B., Cybulski, C., Rubinstein, W., Buys, S., Townshend, S., Friedman, E., Domchek, S., Ramon Y Cajal, T., Spigelman, A., Teo, S., Nicolai, N., Aaronson, N., Ardern-Jones, A., Bangma, C., Dearnaley, D., Eyfjord, J., Falconer, A., Grönberg, H., Hamdy, F., Johannsson, O., Khoo, V., Kote-Jarai, Z., Lilja, H., Lubinski, J., Melia, J., Moynihan, C., Peock, S., Rennert, G., Schröder, F., Sibley, P., Suri, M., Wilson, P., Bignon, Y., Strom, S., Tischkowitz, M., Liljegren, A., Ilencikova, D., Abele, A., Kyriacou, K., Van Asperen, C., Kiemeney, L., Easton, D., Eeles, R. (2011), Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU international. 107(1), 28-39. [Abstract]

2010

   
  • Saleh, M., Barlow-Stewart, K., Meiser, B., Tucker, K., Eisenbruch, M., Kirk, J. (2010), Knowledge, attitudes and beliefs of Arabic-Australians concerning cancer. Psycho-Oncology. 21(2), 195-202. [Abstract]
  • Zilliacus, E., Meiser, B., Lobb, E., Kirk, J., Warwick, L., Tucker, K. (2010), Women's Experience of Telehealth Cancer Genetic Counseling. Journal of genetic counseling. 19(5), 463-72. [Abstract]
  • Whitaker, H., Kote-Jarai, Z., Ross-Adams, H., Warren, A., Burge, J., George, A., Bancroft, E., Jhavar, S., Leongamornlert, D., Tymrakiewicz, M., Saunders, E., Page, E., Mitra, A., Mitchell, G., Lindeman, G., Evans, D., Blanco, I., Mercer, C., Rubinstein, W., Clowes, V., Douglas, F., Hodgson, S., Walker, L., Donaldson, A., Izatt, L., Dorkins, H., Male, A., Tucker, K., Stapleton, A., Lam, J., Kirk, J., Lilja, H., Easton, D., Cooper, C., Eeles, R., Neal, D. (2010), The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PloS one. 5(10), e13363. [Abstract]
  • Kirk, J. (2010), Genetic Testing for Cancer Susceptibility: How and When?. In: When Cancer Crosses Disciplines: A Physician's Handbook. (pp.931-940).London, UK: Imperial College Press.
  • Antill, Y., Mitchell, G., Johnson, S., Devereux, L., Milner, A., Di Iuiio, J., Lindeman, G., Kirk, J., Phillips, K., Campbell, I. (2010), Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 19(1), 265-274. [Abstract]

2009

   
  • Shanley, S., Fung, C., Milliken, J., Leary, J., Barnetson, R., Schnitzler, M., Kirk, J. (2009), Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Familial cancer. 8(3), 251-5. [Abstract]

2008

   
  • Juan, A., Wakefield, C., Kasparian, N., Kirk, J., Tyler, J., Tucker, K. (2008), Development and Pilot Testing of a Decision Aid for Men Considering Genetic Testing for Breast and/or Ovarian Cancer-Related Mutations (BRCA1/2). Genetic Testing. 12(4), 523-532. [Abstract]
  • Wakefield, C., Meiser, B., Homewood, J., Ward, R., O'Donnell, S., Kirk, J. (2008), Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer. 113(5), 956-965. [Abstract]
  • Wakefield, C., Meiser, B., Homewood, J., Peate, M., Taylor, A., Lobb, E., Kirk, J., Young, M., Williams, R., Dudding, T., Tucker, K. (2008), A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast cancer research and treatment. 107(2), 289-301. [Abstract]

2007

   
  • Wakefield, C., Meiser, B., Homewood, J., Peate, M., Kirk, J., Warner, B., Lobb, E., Gaff, C., Tucker, K. (2007), Development and pilot testing of two decision AIDS for individuals considering genetic testing for cancer risk. Journal of Genetic Counseling. 16(3), 325-339. [Abstract]
  • Field, M., Shanley, S., Kirk, J. (2007), Inherited cancer susceptibility syndromes in paediatric practice. Journal of Paediatrics and Child Health. 43(4), 219-229. [Abstract]
  • Kirk, J. (2007), The role of familial cancer services. Cancer Forum. 31, 136-138.
  • Featherstone, C., Colley, A., Tucker, K., Kirk, J., Barton, M. (2007), Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence. British Journal of Cancer. 96(2), 391-398.
  • Wakefield, C., Kasparian, N., Meiser, B., Homewood, J., Kirk, J., Tucker, K. (2007), Attitudes Toward Genetic Testing for Cancer Risk after Genetic Counseling and Decision Support: A Qualitative Comparison between Hereditary Cancer Types. Genetic Testing. 11(4), 401-412. [Abstract]